Filing Details

Accession Number:
0001735276-23-000038
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-04-10 16:29:17
Reporting Period:
2023-04-06
Accepted Time:
2023-04-10 16:29:17
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1178670 Alnylam Pharmaceuticals Inc. ALNY Pharmaceutical Preparations (2834) 770602661
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1708764 Lall Indrani Franchini 675 West Kendall Street
Henri A. Termeer Square
Cambridge MA 02142
Evp, Clo & Secretary No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2023-04-06 3,500 $210.00 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 16, 2022.